Investigational Drug Information for Pimodivir
✉ Email this page to a colleague
What is the development status for investigational drug Pimodivir?
Pimodivir is an investigational drug.
There have been 5 clinical trials for Pimodivir.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 3rd 2018.
The most common disease conditions in clinical trials are Influenza, Human, Liver Diseases, and Renal Insufficiency. The leading clinical trial sponsors are Janssen-Cilag International NV, Janssen Research & Development, LLC, and [disabled in preview].
There are thirty-eight US patents protecting this investigational drug and one hundred and thirty-seven international patents.
Summary for Pimodivir
| US Patents | 38 |
| International Patents | 137 |
| US Patent Applications | 91 |
| WIPO Patent Applications | 17 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 1 (2018-01-03) |
| Vendors | 40 |
Recent Clinical Trials for Pimodivir
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Orally Administered Pimodivir in Adult Participants With Renal Impairment | Janssen-Cilag International NV | Phase 1 |
| A Study of Orally Administered Pimodivir in Adult Participants With Hepatic Impairment | Janssen-Cilag International NV | Phase 1 |
| A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults | Janssen-Cilag International NV | Phase 1 |
Clinical Trial Summary for Pimodivir
Top disease conditions for Pimodivir
Top clinical trial sponsors for Pimodivir
US Patents for Pimodivir
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Pimodivir | ⤷ Start Trial | Methods of preparing inhibitors of influenza viruses replication | Vertex Pharmaceuticals Incorporated (Boston, MA) | ⤷ Start Trial |
| Pimodivir | ⤷ Start Trial | Inhibitors of influenza viruses replication | Vertex Pharmaceuticals Inc | ⤷ Start Trial |
| Pimodivir | ⤷ Start Trial | Aza-pyridone compounds and uses thereof | Alios BioPharma, Inc. (South San Francisco, CA) | ⤷ Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Pimodivir
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Pimodivir | Australia | AU2014348752 | 2033-11-13 | ⤷ Start Trial |
| Pimodivir | Australia | AU2019203656 | 2033-11-13 | ⤷ Start Trial |
| Pimodivir | Australia | AU2021204970 | 2033-11-13 | ⤷ Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
